The Syneos Health Consulting Dealmakers' Intentions is a forward-looking measure of dealmaking activity in the pharmaceutical and biotech industries. While there are many quality sources of information that look historically at past deal trends, this survey offers a prospective view of the partnering and licensing landscape for the year ahead. Now in its 12th year, this survey provides a unique perspective on these trends – by surveying business development professionals such as yourself, from pharmaceutical and biotechnology companies of all sizes, we are able to generate forward-looking insights based on dealmakers' general expectations for activity in the coming year.

We invite you to participate in this study. It should only take about 20 minutes; the first 150 participants will receive an Amazon gift card. All information collected during the survey will be held in confidence and presented at a summary level with no individual attributions. We would like you to feel comfortable to answer all questions candidly. We realize you are very busy, and we appreciate your taking the time to participate in this landmark study.

You can access the survey by clicking the button below.

When you are finished, we also invite you to review the results of last year's Dealmakers' Intentions Study, here.

Connect with us

Message above is a paid advertisement. Content is provided by the sponsor. You received this email because you are a customer of Pharmaceutical Executive, an MJH Life Sciences™ brand. You are on the mailing list as %%emailaddress%%.